188 related articles for article (PubMed ID: 12628652)
1. Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta.
Minutolo F; Antonello M; Bertini S; Rapposelli S; Rossello A; Sheng S; Carlson KE; Katzenellenbogen JA; Macchia M
Bioorg Med Chem; 2003 Apr; 11(7):1247-57. PubMed ID: 12628652
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
Tuccinardi T; Bertini S; Martinelli A; Minutolo F; Ortore G; Placanica G; Prota G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
J Med Chem; 2006 Aug; 49(16):5001-12. PubMed ID: 16884312
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes.
Ghosh U; Ganessunker D; Sattigeri VJ; Carlson KE; Mortensen DJ; Katzenellenbogen BS; Katzenellenbogen JA
Bioorg Med Chem; 2003 Feb; 11(4):629-57. PubMed ID: 12538029
[TBL] [Abstract][Full Text] [Related]
4. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
Minutolo F; Bertini S; Granchi C; Marchitiello T; Prota G; Rapposelli S; Tuccinardi T; Martinelli A; Gunther JR; Carlson KE; Katzenellenbogen JA; Macchia M
J Med Chem; 2009 Feb; 52(3):858-67. PubMed ID: 19128016
[TBL] [Abstract][Full Text] [Related]
5. Salicylaldoxime moiety as a phenolic "A-Ring" substitute in estrogen receptor ligands.
Minutolo F; Bertini S; Papi C; Carlson KE; Katzenellenbogen JA; Macchia M
J Med Chem; 2001 Nov; 44(24):4288-91. PubMed ID: 11708930
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
7. Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists.
Stauffer SR; Huang YR; Aron ZD; Coletta CJ; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
Bioorg Med Chem; 2001 Jan; 9(1):151-61. PubMed ID: 11197335
[TBL] [Abstract][Full Text] [Related]
8. ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4'-hydroxyphenyl-aryl-carbaldehyde oxime derivatives.
Mewshaw RE; Bowen SM; Harris HA; Xu ZB; Manas ES; Cohn ST
Bioorg Med Chem Lett; 2007 Feb; 17(4):902-6. PubMed ID: 17188490
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
Meyers MJ; Sun J; Carlson KE; Marriner GA; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2001 Nov; 44(24):4230-51. PubMed ID: 11708925
[TBL] [Abstract][Full Text] [Related]
10. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
Minutolo F; Bellini R; Bertini S; Carboni I; Lapucci A; Pistolesi L; Prota G; Rapposelli S; Solati F; Tuccinardi T; Martinelli A; Stossi F; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
J Med Chem; 2008 Mar; 51(5):1344-51. PubMed ID: 18269232
[TBL] [Abstract][Full Text] [Related]
11. Acyclic amides as estrogen receptor ligands: synthesis, binding, activity and receptor interaction.
Stauffer SR; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
Bioorg Med Chem; 2000 Jun; 8(6):1293-316. PubMed ID: 10896109
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
[TBL] [Abstract][Full Text] [Related]
13. Diaryl-substituted salicyl- and anthranyl-ketoximes as potential estrogen receptor ligands.
Minutolo F; Antonello M; Bertini S; Placanica G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
Farmaco; 2004 Aug; 59(8):601-7. PubMed ID: 15262529
[TBL] [Abstract][Full Text] [Related]
14. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
Minutolo F; Antonello M; Bertini S; Ortore G; Placanica G; Rapposelli S; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
J Med Chem; 2003 Sep; 46(19):4032-42. PubMed ID: 12954056
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structural evaluation, and estrogen receptor interaction of 2,3-diarylpiperazines.
Gust R; Keilitz R; Schmidt K
J Med Chem; 2002 May; 45(11):2325-37. PubMed ID: 12014971
[TBL] [Abstract][Full Text] [Related]
16. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
Barkhem T; Carlsson B; Nilsson Y; Enmark E; Gustafsson J; Nilsson S
Mol Pharmacol; 1998 Jul; 54(1):105-12. PubMed ID: 9658195
[TBL] [Abstract][Full Text] [Related]
17. Development of selective estrogen receptor modulator (SERM)-like activity through an indirect mechanism of estrogen receptor antagonism: defining the binding mode of 7-oxabicyclo[2.2.1]hept-5-ene scaffold core ligands.
Zheng Y; Zhu M; Srinivasan S; Nwachukwu JC; Cavett V; Min J; Carlson KE; Wang P; Dong C; Katzenellenbogen JA; Nettles KW; Zhou HB
ChemMedChem; 2012 Jun; 7(6):1094-100. PubMed ID: 22517684
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
[TBL] [Abstract][Full Text] [Related]
19. Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members.
Kraichely DM; Sun J; Katzenellenbogen JA; Katzenellenbogen BS
Endocrinology; 2000 Oct; 141(10):3534-45. PubMed ID: 11014206
[TBL] [Abstract][Full Text] [Related]
20. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
